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Abstract 
 The influence of sprint training on endogenous urinary purine loss was examined in 
seven active male subjects (age: 23.1 ± 1.8 years, weight: 76.1 ± 3.1 kg, VO2peak: 
56.3 ± 4.0 ml.kg-1.min-1). Each subject performed a 30s sprint performance test (PT), 
before and after 7 days of sprint training. Training consisted of fifteen 10s sprints on 
an air-braked cycle ergometer performed twice per day. A rest period of 50s separated 
each sprint during training. Sprint training resulted in a 20% higher muscle ATP 
immediately after PT, a lower IMP (57% and 89%, immediately following and after 
10 min recovery from PT, respectively), and inosine accumulation (53% and 56%, 
immediately following and 10 min after the PT, respectively).  Sprint training also 
attenuated the exercise-induced increases in plasma inosine, hypoxanthine (Hx) and 
uric acid during the first 120 min of recovery and reduced the total urinary excretion 
of purines (inosine + Hx + uric acid) in the 24 hours recovery following intense 
exercise. These results show that intermittent sprint training reduces the total urinary 
purine excretion after a 30s sprint bout.  
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Introduction 
The ATP content of untrained human skeletal muscle is about 20-25 mmol.kg-1 dry 
mass (d.m.), and several reports have demonstrated that intense intermittent sprint 
training can lower the resting content by up to 20% (Hellsten-Westing et al. 1993a; 
Stathis et al. 1994; Hellsten et al. 2004). The factors responsible for the set point of 
resting muscle adenine nucleotide (AdN=ATP+ADP+AMP) content are unknown, 
however, it is influenced by the balance between loss of purine base from the muscle 
and its production via de novo purine synthesis. Intense exercise results in a transient 
reduction of ATP and concomitant accumulation of IMP (Stathis et al. 1994). Most of 
this IMP is rapidly resynthesised to ATP during recovery, although a small portion is 
further degraded and results in the production of the purine bases inosine and 
hypoxanthine (Hx; Stathis et al. 1994). Purine bases, not recovered intramuscularly 
via purine salvage, efflux the muscle (Hellsten et al. 1999) and accumulate in the 
plasma (Bangsbo et al. 1992; Tullson et al. 1995; Stathis et al. 1999). Once in the 
plasma purine bases are not recovered by skeletal muscle (Hellsten et al. 1999). The 
magnitude of purine loss can be between 5% and 9% of the resting muscle ATP 
content (Bangsbo et al. 1992; Hellsten et al. 1999). It has been reported that the 
plasma purines are excreted in the urine (Nasrallah and Al Khalidi 1964; Sutton et al. 
1980; Stathis et al. 1999), or converted to uric acid (Hellsten et al. 1994) and 
subsequently excreted (Nasrallah and Al Khalidi 1964; Sorensen and Levinson 1975; 
Stathis et al. 1999). Sorensen and Levison (1975) demonstrated that, in a resting 
individual, the uric acid loss via the gut is one third, whilst via the urine is two thirds 
of the total uric acid loss in the untrained individual.  
Exercise intensity and duration can influence the plasma purine accumulation in 
recovery (Sjödin and Hellsten-Westing 1990; Hellsten et al. 1999), as does the 
frequency and number of intermittent sprint bouts (Balsom et al. 1992a; Balsom et al. 
1992b; Stathis et al. 1999). The number of repetitions in a sprint challenge also 
influences the excretion of urinary purines during recovery (Stathis et al. 1999). 
Sprint training reduces the accumulation of IMP (Stathis et al. 1994; Harmer et al. 
2000; Parra et al. 2000) and inosine (Stathis et al. 1994) in the muscle following an 
intense sprint. Furthermore, sprint training attenuates the plasma inosine, Hx and uric 
acid accumulation during recovery from an intense exercise bout (Stathis et al. 1994). 
However, the effect of sprint training on urinary purine excretion following a 
maximal sprint bout is unknown. 
The aim of this study was to investigate the effects of an intense seven-day sprint 
training program on the loss of endogenous purine metabolites in the urine during 
recovery from an intense sprint bout. It was hypothesised that sprint training will 
reduce the accumulation of muscle IMP and inosine during a 30 s print bout and 
attenuate the concentration of plasma purine metabolites, inosine, Hx and uric acid, 
during recovery from a 30 s sprint bout, consistent with previous studies. This will 
lead to a reduction in urinary excretion of purine metabolites during recovery from the 
sprint. 
 
Methods 
Subjects. Seven active, non-specifically trained males (age: 23.1 ± 1.8 years, weight: 
76.1 ± 3.1 kg, VO2peak: 56.3 ± 4.0 ml.kg-1.min-1), volunteered for the study, which 
was approved by the Victoria University Human Research Ethics Committee. All 
subjects were fully informed of the experimental procedures and voluntarily 
consented to take part in the study. 
Peak oxygen consumption (VO2peak). The VO2peak of each subject was determined 
approximately one week prior to beginning the experimental trials. The exercise 
protocol involved riding on a cycle ergometer (Lode, Groningen) for three min at 
three submaximal work rates, after which the work rate was increased every min 
thereafter until volitional exhaustion. Expired air was directed by a Hans Rudolph 
valve through a ventilometer (Pneumoscan S30) into a mixing chamber and analysed 
for oxygen and carbon dioxide content by gas analysers (Applied Electrochemistry S-
3A O2 and CD-3A CO2). These analysers were calibrated before each test using 
commercially prepared gas mixtures. Oxygen consumption was calculated by a 
microprocessor using standard equations.  
Sprint testing protocol. Performance tests (PT) were 30s maximal sprints completed 
before and after a training regime. These were performed on an air-braked cycle 
ergometer, modified to enable computerized determination of peak power and mean 
power. Fatigue index (FI) was calculated using the equation FI = (peak power – 
power at the end of 30 s exercise)/ peak power x 100. The power output of the air-
braked cycle ergometer is approximately proportional to the cube of the wheel 
velocity, which was measured using a tachometer (Hall-effect device and a cog at the 
wheel hub). The subjects were instructed to remain seated and pedal as fast as 
possible for the 30s exercise periods. Subjects were familiarised with the sprint task at 
least one week prior to the PT. The final PT was performed at least 24 hours and less 
than 36 hours following the last training session. The subjects were also instructed to 
refrain from strenuous exercise, caffeine and alcohol consumption 24 hours prior to 
the PT. In addition, subjects recorded their diet for the 24 hours prior to the first PT 
and were asked to consume similar foods before the final PT. All PT were conducted 
in the morning after an overnight fast. During the first 15 min of recovery from each 
PT the subjects ingested 500 ml of water. Subjects were also provided with food 
(snack bar, fruit juice and salad sandwich) after two hours of recovery in each trial 
and were restricted from any other food intake until after an 8 hour urine sample was 
obtained.   
Training protocol. Sprint training was performed twice per day for a week and each 
session was separated by at least 6 hours. A training session involved 15 x 10s 
maximal cycling bouts on an air-braked cycle ergometer with 50-s of rest between 
bouts.  
Blood and urine sampling, treatment and analysis. Blood was sampled from an 
antecubital vein, via an indwelling catheter, at rest, and following 0, 10, 15, 20, 30, 60 
and 120 min of passive recovery after the PT. The blood was immediately placed into 
lithium heparin tubes and spun in a centrifuge. Subsequently, 100 µl of plasma were 
added to 200 µl of ice-cold 3 M perchloric acid, spun and the supernatant was stored 
at -80 oC before analysis for lactate. Plasma lactate was determined in duplicate, using 
an enzymatic spectrophotometric technique (Lowry and Passoneau 1972). The 
remaining plasma was stored in liquid nitrogen for analysis of inosine, Hx and uric 
acid. The plasma stored for these metabolites was deproteinised with 1.5 M perchloric 
acid and subsequently neutralised with 2.1 M potassium hydrogencarbonate 
immediately prior to analysis. Plasma Hx, inosine and uric acid were determined on 
neutralised perchloric acid extracts, using a modification of the reverse-phase high 
performance liquid chromatography (HPLC) technique described by Wynants and 
Van Belle (1985). Separation was achieved using a Merck Hibar Lichrosphere 100 
CH-18/2 250 x 4 mm column with the use of a Waters chromatography workstation.  
Urine was collected for 12 hrs prior to the PT and for the first 2, and the subsequent 6, 
and 16 hour periods following the PT. Urine volume was determined and an aliquot of 
the samples were stored at –80oC before analysis. Samples were deproteinised, 
neutralised and analyzed for inosine, Hx and xanthine using the same sample 
treatment and HPLC procedures as described for plasma. Urinary uric acid 
concentration was determined by an enzymatic colorimetric method using a Beckman 
Synchron CX ® system. Exercise-induced endogenous urinary purine excretion was 
determined by calculating the difference in excretion rate during recovery from the 
PT, relative to the pre-PT basal excretion rate. 
Muscle sampling treatment and analysis. Muscle biopsies were obtained from the 
vastus lateralis under local anasthesia (1% xylocaine) using the percutaneous needle 
biopsy technique. Muscle was sampled from the same leg from separate incisions at 
rest, immediately after exercise, and 10 min into recovery. Leg selection was random 
with the contralateral leg biopsied in the second PT . Muscle samples were frozen in 
liquid nitrogen within 5 s of obtaining biopsies. Samples were weighed at –30oC and 
freeze-dried, weighed, dissected free of any connective tissue, powdered, and 
extracted according to the method of Harris et al. (1974). The neutralized extract was 
assayed enzymatically for phosphocreatine (PCr), creatine, and lactate by 
fluorometric analyses (Lowry and Passoneau 1972). Reverse-phase HPLC was used 
to quantify ATP, ADP, AMP, IMP, inosine and hypoxanthine concentrations using 
the method of Wynants and Van Belle (1985) with the same apparatus as described 
for plasma analysis. Muscle ATP, ADP, AMP, IMP, Cr and PCr were adjusted to the 
peak total creatine content for each subject in each PT for pre and post-training trials.  
Statistical analysis. All values are reported as means ± SE. Where appropriate, the 
metabolite and performance data were analysed using analysis of variance (ANOVA) 
with repeated measures (BMDP statistical software). Simple main effects analyses 
and Newman-Kuels post hoc tests were used to locate differences when ANOVA 
revealed a significant interaction. Comparison of performance variables, total creatine 
content and urinary purine loss during recovery were analysed using paired-sample T-
Tests. The level of probability to reject the null hypothesis was set at P≤0.05.  
 
Results 
Performance variables. No change in the peak power (1085.1 ± 40.3 v 1081.7 ± 38; 
untrained vs trained), mean power (617.9 ± 20.4 v 630.4 ± 10.1) or fatigue index 
(58.9 ± 1.6% v 57.5 ± 1.4%) was observed with sprint training.  
 
Muscle metabolites . The muscle metabolite content at rest, immediately post-exercise 
and 10 min into recovery are summarised in Table 1. No differences were observed 
with resting muscle metabolites before and after training. The resting ATP levels 
showed a tendency to be lower after training using different analytical methods 
(p=0.06 and 0.13, enzymatic and HPLC methods, respectively). Exercise decreased 
muscle ATP in both the pre- and post-training PT but the levels upon termination of 
exercise was significantly higher in the post-trained compared with the pre-trained 
state (Table 1). Concomitantly, sprint exercise resulted in an accumulation of IMP and 
inosine, however, the end exercise IMP and inosine were lower (P<0.05) with training 
(Table 1). The PCr, Cr and lactate levels after exercise were unaffected by the 
training.  
The ATP content was partially restored 10 min into recovery from post-exercise 
values, but was still lower than pre-exercise amounts, irrespective of training status. 
Additionally, the levels of ATP at 10 min recovery were not different between trials. 
Similarly, the IMP content reduced during recovery but had not returned to resting 
levels in both trained and untrained states at 10 min. Muscle inosine continued to 
increase during recovery in both trials, however the content was lower post-training 
compared with pre-training (Table 1). The PCr and Cr levels at 10 min recovery 
following training were not different to pre-exercise levels, whereas they were 
significantly lower and higher, respectively, than rest in the untrained state. Muscle 
lactate levels during recovery were not affected by training. Muscle ADP and AMP 
were not different following PT and 10 min recovery and were not different across 
training. The mean total creatine was higher in the post-trained state (123.1 ± 5.2 vs 
131.5 ± 6.4; P<0.05, untrained vs. trained, respectively).  
 
Plasma metabolite concentrations.  The resting concentration of all measured 
metabolites were similar pre- and post-training (Fig 1). Training resulted in 
significantly lower levels of inosine in the 15-30 min (Fig 1A) and hypoxanthine in 
the 15-60 min (Fig 1B) period of recovery, whilst uric acid was lower with training 
from 60 min to the end of measurement (120 min; Fig 1C). Plasma lactate was not 
different at any time-point of recovery with training (data not shown). 
 
Urinary excretion. Urinary excretion of inosine, Hx and uric acid was elevated 
during the first 2 hour period after exercise. It should be noted that there was a 
reduction in inosine excretion in the trained compared with the untrained state after 2 
hours (Fig 2A) and a lower uric acid excretion in the 24 hour recovery period 
following PT with training (Fig 2B). The total endogenous purine metabolite (inosine 
+ Hx + uric acid) excretion was not different in the first 2 hours (Fig 2A; 775±133 v 
739±108 µmoles, untrained v trained, respectively). However, there was a tendency 
(p=0.12) for an attenuated excretion with training after 8 hours recovery, (not shown; 
1378±213 v 981± 141 µmoles; respectively) and a reduced (p<0.05) excretion in the 
24 hour recovery period (1603±267 v 1237±264 µmoles, untrained vs trained, 
respectively; Fig 2B).  
 
Discussion 
Sprint training reduced the muscle (Table 1) and plasma purine concentrations (Fig 1) 
and the excretion of urinary purines during recovery from a 30s sprint bout (Fig 2). 
This reduction likely represents a training-induced adaptation to minimise the loss of 
purines from skeletal muscle. Such an adaptation is advantageous in reducing the 
subsequent metabolic cost of AdN replacement by the purine de novo biosynthesis 
pathway.  
As expected sprint training reduced the extent of ATP degradation (44.6%) and the 
IMP and inosine accumulation (56.7% and 66%, respectively) in the muscle during a 
30 s sprint. A similar finding has been reported in other studies (Stathis et al. 1994; 
Harmer et al. 2000; Parra et al. 2000) and demonstrates an improved balance between 
the rates of ATP degradation and resynthesis with sprint training. Assuming any 
contribution of altered exercise efficiency per se is likely to be minimal, the rate of 
ATP degradation during the PT is likely to be the same as the peak and mean power 
values were not different pre and post-training. Thus, a more likely explanation is a 
training-induced improvement in the re-phosphorylation rate of ATP; either through 
anaerobic or aerobic sources. 
The magnitude of the PCr degradation during the PT was not different following 
training indicating it does not contribute to an enhanced ATP resynthesis rate. Other 
contributing factors to ATP resynthesis include anaerobic glycolysis and oxidative 
phosphorylation. There is evidence of increased enzymatic activities of anaerobic 
glycolysis (phosphofructokinase and aldolase) with sprint training (Parra et al. 2000), 
that could contribute to improved ADP re-phosphorylation. However, the present data 
indicate that anaerobic glycolysis was not likely to contribute to the improved ATP 
resynthesis rates following sprint training as the muscle lactate accumulation (Table 
1) and the plasma lactate recovery profiles were not different with training (data not 
shown). An increasing body of evidence suggests there is an increase in the oxidative 
potential of skeletal muscle following sprint training (Parra et al. 2000; Burgomaster 
et al. 2005). Clearly no oxygen consumption or muscle aerobic enzyme activity were 
measured in the current study so we are unable to provide any evidence to support 
that notion that aerobic metabolism was enhanced in the sprint trained state. The 
tempered accumulation of IMP observed during the PT with sprint training (Table 1) 
must be due to a reduced flux through AMPd or an increased activity of pathways 
utilising IMP. Although it is not clear how the different modulators influence AMPd 
during intense exercise in vitro studies have demonstrated increases in AMPd activity 
with elevated substrate availability (Raggi and Ranieri-Raggi 1987) and increased 
concentrations of ADP, AMP and H+ (Wheeler and Lowenstein 1979; Lowenstein 
1990). Inhibition of AMPd occurs with elevated orthophosphate, ATP and guanosine 
5’-triphosphate (GTP; Wheeler and Lowenstein 1979; Lowenstein 1990).  Hence a 
reduced net production of AMP with the abovementioned improvement in the balance 
between ATP hydrolysis and ATP resynthesis rates best explains the reduced IMP 
accumulation following the PT with sprint training (Table 1). Other factors that 
influence AMPd activity, such as PCr content (Rush et al. 1998), are unlikely to play 
a role in the reduced AMPd activity in the trained state as the PCr content in mixed 
muscle was the same at the end point of exercise in the PT (Table 1). Furthermore, the 
attenuated accumulation of IMP observed following the PT during sprint training is 
not likely due to increased degradation of IMP to inosine or reamination to AMP via 
the purine nucleotide activity (PNC). A small but significant sprint-trained reduction 
in inosine content following the PT (Table 1) indicates that an elevated degradation of 
IMP to inosine is unlikely. Evidence from rodent muscle demonstrates that the purine 
nucleotide cycle does not operate in muscles contracting during high intensity 
exercise (Meyer and Terjung 1980). Furthermore, sprint training attenuated plasma 
inosine, Hx and uric acid concentrations during the first two hours of recovery 
following the sprint (Fig 2). Lower plasma Hx following training has been reported in 
an earlier training study (Stathis et al. 1994) and is best explained by a reduction in 
the magnitude of purine efflux from the muscle, although no experimental evidence is 
available to confirm this possibility.  
Urinary purine excretion in the 24 hours after the PT was reduced following sprint 
training (Fig 3) and is best explained by a decreased delivery of purine to the kidney 
due to lower plasma purine concentration. Attenuated plasma purine is a likely result 
of lower muscle purine base production and efflux into the plasma. The lower urinary 
purine excretion may also be influenced by a training-induced change in the loss of 
purines via the gut (Sorensen and Levinson 1975). Sorensen and Levinson (1975) 
demonstrated that in normal untrained individuals one third of basal uric acid 
excretion occurs via the gut and, as yet, no studies have investigated the influence of 
intense exercise and/or sprint training on this avenue of purine loss.  
Previous studies have reported reduced resting muscle ATP after sprint training 
(Hellsten-Westing et al. 1993a; Stathis et al. 1994; Hellsten et al. 2004). A significant 
reduction in resting ATP following a similar training protocol to that used in this 
study was achieved with nine (Hellsten-Westing et al. 1993a) and eight (Hellsten et 
al. 2004) participants. The current study demonstrates a strong tendency for a lower 
resting ATP levels in the muscle after sprint training (Table 1; p=0.06 and 0.13, 
enzymatic and HPLC analysis, respectively). A greater number of participants will be 
required to clarify the situation, as the statistical power of the test for detecting a 
significant decrease is low (i.e., 38%) in the present study indicating that a Type 2 
error is likely. The imbalance between ATP loss and its resynthesis/synthesis is 
considered to be responsible for the reduction in resting muscle ATP content. 
Assuming the elevation in purine excretion during recovery represents the loss of 
endogenous purines from the active muscle, the loss of purine metabolites in 24 hours 
recovery from an intense sprint bout represents around 2% of the resting ATP content 
in the untrained and trained state. This was estimated by calculating the extent of 
purine excretion relative to the active muscle. If skeletal muscle is 40% of body 
weight (76.1 kg) and the legs comprise 55% of the total muscle mass (Snyder et al. 
1975), then the mean weight of the exercising muscle (both legs) is 3.85 kg d.m. 
(assuming 23% dry weight). The urinary purine loss is probably an underestimate, as 
uric acid can also cross into the gut (Sorensen and Levinson 1975). As well as 
reducing the production of purines in the muscle, the conservation of muscle purine 
nucleotides with sprint training could also be enhanced by an increased capacity of 
intramuscular purine recovery after sprint training. Evidence of an elevated activity of 
the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase 
(HGPRT) following sprint training (Hellsten-Westing et al. 1993b) supports this 
possibility and provides a mechanism to further reduce the loss of purines from the 
muscle following exercise in the trained state. 
Interestingly, seven days of intense sprint training resulted in no differences in mean 
power, peak power or the fatigue index during a 30 sec maximal sprint cycle bout. 
These results are consistent with those reported after a similar training protocol 
(Hellsten-Westing et al. 1993a). The training protocol may limit any performance 
improvement because there is inadequate recovery time between sessions to produce 
optimal training adaptation. In support of this, Parra et al. (2000) demonstrated that a 
training programme using the same training load but over a longer duration improved 
performance in a 30 s sprint test. 
In conclusion, the present study demonstrated that sprint training reduced purine base 
accumulation in the muscle and plasma, and decreased urinary excretion of 
endogenous purines (inosine, Hx and uric acid) following maximal sprint exercise. An 
attenuated loss of muscle purine nucleotide degradation products after a sprint bout 
reduces the extent of replacement of the muscle nucleotide pool via the metabolically 
expensive purine de novo synthesis pathway. 
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Table 1: Effect of seven days of sprint training on skeletal muscle metabolites at rest, 
after a 30s sprint and 10 min recovery. 
    Untrained     Trained   
  Rest Exercised 10 min 
recovery 
Rest Exercise 10 min recovery
ATP 24.05±1.24 13.35±1.62 a 18.70±2.03 a,b 21.16±0.80 16.12±1.56* a 19.09±0.85 a,b
ATP-hplc 22.01±1.28 12.49±1.27 a 17.47±1.34 19.65±0.80 15.40±1.24* a 17.49±0.78 a,b
ADP 1.60±0.22 1.57±0.21 1.63±0.26 1.64±0.23 1.70±0.25 1.50±0.23 
AMP 0.05±0.01 0.05±0.01 0.05±0.01 0.05±0.01 0.06±0.01 0.05±0.01 
IMP 0.04±0.02 7.08±1.19 a 3.97±0.37 a,b 0.04±0.02 3.06±0.41* a 0.42±0.11 * a,b
Inosine 0.01±0.00 0.13±0.02 0.96±0.12 a,b 0.02±0.01 0.06±0.01* 0.42±0.07 *a,b
Hypoxanthine <0.01 <0.01 0.04±0.00 a,b <0.01 <0.01 0.03±0.01 a,b 
PCr 82.0±3.7 27.3±4.4 a 71.9±3.8 a,b 87.4±3.7 31.5±4.1 a 83.8±4.3 b 
Creatine 45.3±3.2 100.1±4.0 a 55.5±4.8 a,b 48.4±5.1 104.4±3.3 a 52.1±7.0 b 
Lactate 5.51±0.63 91.90±7.51 a 49.37±6.46 a,b 5.53±0.99 83.94±5.32 a 39.24±2.53 a,b
AdN  23.67±1.34 14.13±1.35 a 19.16±1.56 a,b 21.36±0.96 17.17±1.41 * a 19.05±0.96 a,b
AdN + IMP + Inosine 23.72±1.34 21.33±0.61 24.10±1.40 21.41±0.97 20.28±1.21 19.89±0.87 
 
Values are means ± SE; n=7; units are mmol.(kg dry weight)-1 * different from untrained, 
p<0.05; a, different from Rest value p<0.05; b, different from Exercise value p<0.05. 
 
 
 
 
 
 
  
Figure Legends 
Fig. 1. Forearm venous plasma inosine (A), hypoxanthine (B), and uric acid (C) 
concentrations at rest (R) and during recovery from a 30s sprint bout before and after 
one week of sprint training. Values are means ± SE, n=7, * different from untrained; 
P<0.05. (note difference in scale). 
 
  
Fig. 2. Exercise endogenous urinary inosine, hypoxanthine, uric acid and total purine 
excretion after (A) 2 hours, and (B) 24 hours, of recovery from a 30s sprint bout 
before and after one week of sprint training. Values are means ± SE, n=7. * different 
from untrained, P<0.05.  
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